Malignant migrating partial seizures of infancy (MMPSI) is a rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay 1 . We performed exome sequencing in three probands with MMPSI and identified de novo gain-of-function mutations affecting the C-terminal domain of the KCNT1 potassium channel. We sequenced KCNT1 in 9 additional individuals with MMPSI and identified mutations in 4 of them, in total identifying mutations in 6 out of 12 unrelated affected individuals. Functional studies showed that the mutations led to constitutive activation of the channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C. In addition to regulating ion flux, KCNT1 has a non-conducting function, as its C terminus interacts with cytoplasmic proteins involved in developmental signaling pathways. These results provide a focus for future diagnostic approaches and research for this devastating condition.
Malignant migrating partial seizures of infancy (MMPSI) is
a rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay 1 . We performed exome sequencing in three probands with MMPSI and identified de novo gain-of-function mutations affecting the C-terminal domain of the KCNT1 potassium channel. We sequenced KCNT1 in 9 additional individuals with MMPSI and identified mutations in 4 of them, in total identifying mutations in 6 out of 12 unrelated affected individuals. Functional studies showed that the mutations led to constitutive activation of the channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C. In addition to regulating ion flux, KCNT1 has a non-conducting function, as its C terminus interacts with cytoplasmic proteins involved in developmental signaling pathways. These results provide a focus for future diagnostic approaches and research for this devastating condition.
First described in 1995, MMPSI is characterized by polymorphous focal seizures and arrest of psychomotor development in the first 6 months of life 1 . Seizures are pharmacoresistant, and ictal electroencephalogram (EEG) discharges arise randomly from various areas of both hemispheres of the brain and 'migrate' from one brain region to another, conferring the main feature and name to this syndrome. Brain magnetic resonance imaging (MRI) is generally normal at the onset of the disease. To date, approximately 80 individuals with MMPSI have been reported, with males and females being equally affected [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
MMPSI belongs to the group of early-onset epileptic encephalopathies (EOEEs) defined as severe age-related disorders where cognitive, sensory and motor impairment is caused by recurrent clinical seizures or prominent interictal epileptiform discharges 18 . There is growing evidence of genetic etiology in EOEEs, with prevalence ranging from 10% of individuals with Ohtahara syndrome having STXBP1 mutations to 70% of individuals with Dravet syndrome having SCN1A mutations 19 . Screening for aberrations in voltage-gated ion channel genes already reported in epilepsies (KCNQ2, KCNQ3, SCN1A, SCN2A and CLCN2) did not detect mutations in these genes in MMPSI 2 . SCN1A mutations were later reported in 2 affected individuals 15, 16 ; however, screening for this gene detected no mutations in 13 individuals with MMPSI 15 .
We collected DNA samples from 12 individuals fulfilling the criteria for diagnosis with MMPSI (Supplementary Table 1 ). Ictal EEG showed migrating seizures ( Supplementary Fig. 1 ), and brain MRI showed delayed myelination with an extremely thin corpus callosum ( Supplementary Fig. 2 ). Clinical and neuroradiological data are detailed in Supplementary Table 1. Molecular screening for SCN1A mutations was negative in all cases.
To identify the disease-causing gene, we performed exome sequencing in 3 of 12 probands and their unaffected parents. We produced 6-8 Gb of sequence for each sample. The mean exome coverage was 63-fold, with 82% of target sequences covered at least 15 times. Considering that all reported cases are sporadic, we searched for de novo dominant mutations and focused primarily on nonsynonymous variants, splice-acceptor and splice-donor site mutations and coding insertions and/or deletions (indels). We considered variants to be previously unidentified if they were absent from control populations, in-house exome data and all publicly available data sets, including dbSNP135, the 1000 Genomes Project database and the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project. Three to four de novo variants fulfilling these criteria were identified per proband (Supplementary Table 2) . A single gene, KCNT1 (MIM 608167; NM_020822.2), was affected by
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy 1 2 5 6 VOLUME 44 | NUMBER 11 | NOVEMBER 2012 Nature GeNetics l e t t e r s distinct heterozygous missense variants in two unrelated probands (c.1283G>A, p.Arg428Gln; c.2800G>A, p.Ala934Thr). Both mutations were confirmed by Sanger sequencing, and none were present in the unaffected parents, consistent with de novo occurrence (Supplementary Fig. 3a) . Both mutations affected a highly conserved amino-acid residue (Supplementary Fig. 3b ) and were absent in 200 healthy controls. We sequenced the KCNT1 coding regions in our nine additional probands and their parents, identifying the same de novo missense mutation encoding p.Arg428Gln in two other affected individuals and two additional distinct de novo mutations in the KCNT1 gene (c.1421G>A, p.Arg474His; c.2280C>G, p.Ile760Met) ( Table 1  and Supplementary Table 2) .
KCNT1 (also known as SLACK, SLO2.2 and KCa4.1) encodes a sodium-activated potassium (K Na ) channel 20 . KCNT1 is widely expressed in the nervous system. Its activity contributes to the slow hyperpolarization that follows repetitive firing. KCNT1 regulates the rate of bursting and enhances the accuracy with which action potentials lock to incoming stimuli 21, 22 . K Na channels also have a role in protecting cells from injury under ischemic conditions 23 . The KCNT1 protein represents the largest known potassium channel subunit. The C-terminal cytoplasmic domain interacts with a protein network, including fragile X mental retardation protein (FMRP), which is a potent stimulator of KCNT1 channel activity 24 . The two aminoacid residues that are altered in MMPSI lie within this functionally important cytoplasmic C-terminal domain (Fig. 1a) . A second gene, KCNT2 (also known as SLICK, SLO2.1 and KCa4.2; MIM 610044), also encodes a K Na channel. Moreover, KCNT1 and KCNT2 assemble to form heterotetrameric channels that differ from the homomers in their unitary conductance, kinetic behavior, subcellular localization and response to activation by protein kinase C (PKC) 25 . We thus hypothesized that KCNT2 mutations may account for disease in some of the individuals with MMPSI who lacked mutations in KCNT1. Direct sequencing of the coding exons of KCNT2 did not identify pathogenic variants.
Although mouse Kcnt1 channels are known to be expressed in neurons of the adult central nervous system 21 , immunostaining experiments have shown that Kcnt1 is also abundantly expressed in embryonic hippocampal and cortical mouse neurons, suggesting the contribution of these cells to early excitability ( Supplementary Fig. 4) .
The transmembrane and C-terminal regions of the human and rat Kcnt1 proteins are 92.0% identical. To evaluate the effect of the p.Arg428Gln and p.Ala934Thr alterations identified in humans, we injected Xenopus laevis oocytes with wild-type and mutant (p.Arg409Gln and p.Ala913Thr) rat Kcnt1 constructs. Both alterations resulted in Kcnt1-generated currents that resembled those of wild-type Kcnt1 channels in terms of voltage dependence and kinetic behavior (Fig. 1a,b) . However, the amplitude of currents produced by the two mutants was two-to threefold greater than that of the currents produced by wild-type Kcnt1 (n = 5 oocytes tested, P < 0.001; Fig. 1c) .
The amplitude of Kcnt1-generated currents is regulated by PKC, which, when activated, produces an approximately two-to threefold increase in current amplitude, similar to that resulting from the p.Arg409Gln and p.Ala913Thr alterations 26 . The p.Arg409Gln alteration affects 1 of the 13 predicted PKC phosphorylation sites on the extended C terminus of Kcnt1 (Fig. 2a) 27 . To determine whether any of these consensus sites regulate the amplitude of Kcnt1-produced currents, we generated mutants in which the relevant serine and threonine residues were individually replaced by an alanine residue. Each of the mutant channels was then expressed in Xenopus oocytes and tested for its electrophysiological response to the PKC activator 12-O-tetradecanoylphorbol-13-acetate (TPA, 100 nM). All 13 mutants produced normal Kcnt1-like currents. By contrast, all but one (with alteration at Ser407) responded to TPA with an increased current comparable to that generated by wild-type channels ( Fig. 2b-d) . Indeed, alteration of the Ser407 residue, which is adjacent to the Arg409 residue altered in MMPSI, completely abolished the TPA response ( Fig. 2c,d ). The proximity of the rat Ser407 and Arg409 residues raised the possibility that the p.Arg409Gln alteration enhances current amplitude by locking the channel into a state similar to that produced by PKC activation. If this were the case, activation by PKC of mutant channels would not be expected to produce further increase in current amplitude. Consistent with this hypothesis, we found that the amplitudes of currents from both the p.Arg409Gln and p.Ala913Thr Kcnt1 channels did not significantly increase in response to TPA (Fig. 2e-g ). The increase in current generated by both altered channels and the lack of response to TPA show that both mutant channels are constitutively active, mimicking and occluding the effects of PKC activation.
To determine whether the p.Arg409Gln and p.Ala913Thr alterations to Kcnt1 produce any other changes in the biophysical behavior of the channels, we carried out single-channel recordings in excised insideout patches (Fig. 3) . The unitary conductance of both mutant channels, determined from the size of single-channel openings at different potentials, was ~140 pS in a solution with internal and external 140 mM [K + ] and was no different from that of the wild-type channels 27 . Moreover, the opening probability of the mutant channels was increased by elevation of sodium ion concentration at the cytoplasmic face of the patches (Fig. 3a,c) , and the dependence of these channels T77A  S93A  T351A  S360A  S407A  S438A  S684A S806A S1096A S1099A S1124A S1221A Water T517A 50 0 Figure 2 MMPSI-associated mutations mimic and occlude the effects of phosphorylation of rat Kcnt1 at Ser407. (a) Schematic of rat Kcnt1 (Slack-B isoform) 22 , including the relative locations of 13 consensus PKC phosphorylation sites and the p.Arg409Gln and p.Ala913Thr alterations. (b,c) Representative families of whole-oocyte currents evoked by stepping from -80 mV to +50 mV in 10-mV increments in oocytes expressing wild-type (WT) rat Kcnt1 (b) or S407A mutant channels (c) before (control) and after application of the PKC activator TPA (100 nM). (d) Relative increases in current (± s.e.m.) at +80 mV for WT rat Kcnt1 or mutants with alanine substitutions at each of the 13 consensus PKC phosphorylation sites measured 20 min after application of TPA (n = 3-5 oocytes for all mutants except for WT and S407A, for which n = 8 each). (e,f) Representative families of wholeoocyte currents evoked by stepping from -80 mV to +80 mV in 10-mV increments in oocytes expressing WT rat Kcnt1 (e) or R409Q mutant channels (f) before and after application of TPA (100 nM). (g) Relative increases in current (± s.e.m.) at +80 mV for WT rat Kcnt1 and the R409Q and A913T mutants 20 min after application of TPA (100 nM) (n = 8 oocytes for WT and 4 for each mutant). 21, 28 . A previous study showed that C-terminal activation of Kcnt1 enhances current amplitude by reducing the probability that the channels open to a subconductance state rather than to the fully open state, which has a higher conductance than that of the subconductance state 24 . Quantification of the openings of the p.Arg409Gln and p.Ala913Thr channels showed that both had reduced openings to these subconductance states compared to wild-type channels (Fig. 3b,d) , consistent with the increased macroscopic currents observed with these alterations.
Our data show that KCNT1 is a major disease-associated gene for MMPSI and demonstrate that the pathophysiological mechanism underlying this disease is constitutive hyperactivation of K Na channels. This is the first epilepsy-associated gene to our knowledge identified by exome sequencing in sporadic cases. This strategy will likely emerge as a powerful approach for unraveling the genetic mechanisms underlying rare epilepsies where familial recurrence is sparse or nonexistent, provided that preliminary phenotyping enables the identification of homogeneous cohorts.
Our findings further confirm the genetic etiology of MMPSI and ascribe MMPSI to the large family of channelopathies. A few affected individuals with MMPSI were reported to have SCN1A mutations. SCN1A is the major gene that is associated with Dravet syndrome, another severe childhood encephalopathy that is phenotypically distinct from MMPSI and is characterized by seizure onset before 1 year of age, with high fever sensitivity, frequent status epilepticus, hemiclonic seizures and later development of various seizure types and mental delay 29 . MMPSI has therefore been included in the SCN1A phenotypic spectrum 15 . However, no other SCN1A mutations or deletions were found in individuals with MMPSI 15, 16 or in this current series. Whereas previous studies have clearly shown that mutations affecting potassium channel subunits can underlie epilepsies, the consequences of the KCNT1 mutations described here appear substantially more severe than those reported for other potassium channels. Mutations in voltage-gated potassium channels KCNQ2 and KCNQ3 have been reported in 20-30% of benign neonatal familial seizures, a syndrome characterized by seizure onset before 2 months of age with cessation before 1 year and good cognitive outcome 30 . Yet, this correlation between mutations affecting voltage-gated potassium channels and benign epilepsies has recently been called into question by the report of a series of individuals with EOEE with KCNQ2 mutations 31 . However, these affected individuals do not present the clinical and EEG characteristics of MMPSI. In addition, KCNT1 encodes a protein belonging to a K Na channel family distinct from the voltage-gated potassium channels that have previously been reported to be affected by mutations in epilepsies. Mutation in KCNMA1, a distant ortholog of KCNT1 with only 7% homology at the protein level 32 , has been shown to account for generalized adult-onset epilepsy and dyskinesia in one family. Notably, the KCNMA1 mutation also led to gain of function, with an increase in channel opening probability 33 .
The difference in clinical outcome between individuals with mutations in KCNT1 and the other potassium channel genes may not simply reflect the effects of the mutations on neuronal excitability. Recent studies have established that, in addition to regulating ion flux, a number of channels have non-conducting functions that regulate biochemical activities independent of ion flux [34] [35] [36] . This is likely to be the case for the KCNT1 channel, which in its C-terminal domain interacts with the mRNA-binding protein FMRP, and may therefore participate in transduction pathways that link neuronal activity to the stimulation of protein synthesis.
Thus, it is likely that the KCNT1 mutations reported here may alter the conformation of the C-terminal region of the protein, impairing not only the gating of the channel but also its ability to interact with developmentally relevant proteins such as FMRP and other cytoplasmic signaling molecules.
Psychomotor outcome in EOEE is usually severe, and the role of epilepsy in this poor outcome remains open for discussion. Along these lines, the expanding phenotypic spectrum of mutations in two genes (the homeobox transcription factor ARX and STXBP1) from severe early-onset epilepsy with mental delay to isolated cognitive delay without epilepsy support the view of an independent developmental role for these genes 37, 38 . Similarly, in tuberous sclerosis complex-a specific type of infantile seizure disorder with developmental delay and autism spectrum disorders-cognitive prognosis is worsened by infantile spasms. However, affected individuals with no or rapidly resolving infantile spasms are also predisposed to cognitive delay and autism spectrum disorders 39 .
Our data identify KCNT1 as a major disease-associated gene in MMPSI. They also suggest that defects in KCNT1, in addition to their effects on ionic currents, may alter developmental signaling pathways coupled to the C terminus of this channel, linking dysfunction of firing, and thus epilepsy, to impaired function of proteins causing arrest of psychomotor development. 
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Methods and any associated references are available in the online version of the paper. 
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Study subjects. We selected individuals presenting with clinical and EEG features of MMPSI who were followed over the last 10 years at the Necker-Enfants Malades Hospital. Twelve affected individuals, five female and seven male, fulfilled the criteria of MMPSI 1,2 (Supplementary Table 1 ). All were born full-term, and none had a history of fetal distress. One was born to first-cousin parents of Moroccan origin. The others were born from non-consanguineous, healthy parents of European origin.
The average age at seizure onset was 2 months (range of 2 h to 7 months). All affected individuals presented polymorphous and focal motor seizures at onset with autonomic components, including cyanosis or bradycardia in four individuals. Seizures were refractory to various antiepileptic drugs that were used mostly in combination (Supplementary Table 1) . EEG disclosed multifocal paroxysmal abnormalities affecting both hemispheres alternatively, and video EEG recordings showed the specific migrating feature in all individuals.
All subjects underwent blood and cerebrospinal fluid (CSF) diagnostic workup, including extensive studies for inborn errors of metabolism, including measures of blood and CSF lactic acid, serum ammonia and lactate, plasma amino-acid and urine organic acid chromatography and Southern blot analysis for congenital disorder of glycosylation. Four affected individuals had a negative study of respiratory chain enzymes in six individuals examined by muscle biopsy and three examined by liver biopsy. Brain MRI was normal at onset and later showed a severe delay in myelinization in seven affected individuals with an extremely thin corpus callosom. No calcification was reported on brain computed tomography (CT). All children developed severe neurological impairment with severe hypotonia and microcephaly ranging from -2.5 to -5 s.d. They showed profound developmental delay. All children exhibited social impairment: they acquired eye contact but no other communication skills (Supplementary Table 1) . Molecular screening excluded SCN1A mutation, deletion or duplication at this locus.
Informed consent was obtained in accordance with the ethical standards of the Institutional Review Board (IRB) on Human Experimentation of the Necker-Enfants Malades Hospital (Paris, France).
Exome sequencing. We collected blood samples from affected individuals and performed massively parallel sequencing. DNA (3 µg) was extracted from leukocyte cells from the cases and was sheared with a Covaris S2 Ultrasonicator. An adaptor-ligated library was prepared with the Paired-End Sample Prep kit V1 (Illumina). Exome capture was performed with the SureSelect Human All Exon kit (Agilent) 40, 41 . Paired-end sequencing was carried out on an Illumina HiSeq 2000 that generated 100-bp reads. For sequence alignment, variant calling and annotation, the sequences were aligned to the reference human genome hg19 using the Burrows-Wheeler Aligner (BWA) 42 . Downstream processing was carried out with the Genome Analysis Toolkit (GATK) 43 , SAMtools 44 and Picard (see URLs). Variant calls were made with the GATK Unified Genotyper. All calls with a read coverage of ≤2× or a Phred-scaled SNP quality score of ≤20 were removed from consideration. All variants were annotated using an annotation software system that was developed in house.
Because MMPSI is likely to be genetically heterogeneous and, therefore, not all affected individuals will carry mutations in the same gene, we looked for candidate genes shared among subsets of affected individuals. Specifically, we searched for subsets in which two-thirds of exomes had at least one previously unknown variant in the same gene.
Mutation detection.
We designed a series of 29 intronic primers to amplify the 31 coding exons of KCNT1. We purified the amplicons and sequenced them using the fluorescent dideoxy terminator method on an automatic sequencer (ABI 3100, Applied Biosystems).
Site-directed mutagenesis. Site-directed mutagenesis of the rat Kcnt1 construct was performed using the QuikChange Mutagenesis kit (Stratagene) and the primers described in Supplementary Table 3 . The presence of mutations and construct fidelity were confirmed by DNA sequencing.
Electrophysiological characterization in Xenopus oocytes. RNA was expressed from the pOX expression vector encoding wild-type or mutant rat Kcnt1 cDNA with an mMessage mMachine T3 kit (Ambion) and aliquoted in sterile water.
Voltage clamp recordings were carried out as described previously 45 using Xenopus oocytes that were defolliculated by collagenase treatment and injected with 100 nl of sterile water containing 20 ng of RNA encoding wild-type Kcnt1 or Kcnt1 mutants or with water alone. Oocytes were incubated at 18 °C, and recordings were carried out 4-5 d after injection. Whole-oocyte currents were measured by a two-electrode voltage clamp amplifier (Warner Instruments). Electrodes were filled with 3 M KCl and had resistances of 0.1-1.0 MΩ. Data were sampled at 1 kHz and filtered at 0.25 kHz. Standard bath solution was MND-96 containing 88 mM NaCl, 1 mM KCl, 2 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM glucose, 5 mM HEPES, 5 mM sodium pyruvate and 50 µg/µl gentamicin (Gibco), pH 7.4. For measurements of channel activation, oocytes were depolarized by 400-ms pulses from a holding potential of -90 mV to test voltages between -80 mV and +80 mV in 10-mV increments every 5 s. TPA was purchased from Sigma-Aldrich. To evaluate the effects of TPA, oocytes were clamped for 20 min, and, every 10 min, the response of the oocytes to 400-ms depolarizing pulses from a holding potential of -90 mV to test pulses of between -80 and +80 mV in 10-mV increments was recorded. Only oocytes with low leak current, in which the current at +80 mV remained unchanged during this time, were included in analysis. TPA was then bath applied to the oocytes, and the protocol was repeated after 20 min.
For patch clamp recording, injected Xenopus oocytes were manually devitellinized in a hypertonic solution containing 220 mM sodium aspartate, 10 mM KCl, 2 mM MgCl 2 and 10 mM HEPES and then incubated in the MND-96 solution for recovery. Excised inside-out patch recordings were performed using a symmetrical 140 mM K + solution containing 100 mM potassium gluconate, 40 mM KCl, 20 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2, 5 mM EGTA and 10 mM HEPES, pH 7.6. Single-channel currents in Xenopus oocytes were recorded using an Axopatch 1D amplifier (Molecular Devices). Currents were filtered at 1 kHz, and data were acquired at 10 kHz. Data recording and analysis were performed using pClamp (Molecular Devices) and Origin 8.0 (Microsoft). To determine sodium ion concentration-response relationships, patches were perfused with solutions containing sodium concentrations from 20-80 mM. The potassium ion concentration was kept constant at 140 mM, and the chloride concentration was kept constant at 40 mM. NP O values were calculated using single-channel search in clampfit and were then normalized to the NP O obtained at 80 mM Na + .
Immunostaining of embryonic neuronal cultures. Rodents were handled in accordance with protocols approved by the Yale University Institutional Animal Care Committee. Primary hippocampal cultures were prepared from embryonic day 17.5 rat brains as described previously 46 and grown in Neurobasal medium supplemented with B27 (Invitrogen). Neurons were plated on coverslips coated with poly-d-lysine (30 µg/ml) and laminin (2 µg/ml) at a density of 50,000 cells per well. After 3 d in vitro, cells were washed twice with 1× PBS with 1% BSA, fixed in 4% paraformaldehyde in phosphate buffer (150 mM NaCl, 100 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 7.4) for 20 min and then blocked with blocking solution for 1 h at room temperature or at 4 °C overnight. After adding the primary antibodies against Kcnt1 (ref. 47) (chicken antibody to Kcnt1; 800 ng/ml), cultures were agitated either for 1 h at room temperature or at 4 °C overnight. Cultures were then washed three times for 10 min each wash, and fluorescent-labeled secondary antibodies were added for 30 min (Alexa Fluor 488-conjugated donkey antibody to chicken; 1:400 dilution). Coverslips were washed first with 1× PBS with 1% BSA three times for 10 min each wash and then mounted onto glass slides with anti-fade polyvinyl alcohol mounting medium with DABCO (Sigma-Aldrich). Images were acquired immediately with a Zeiss laser scanning microscope (LSM 510 META). Diaminobenzedine staining was performed on hippocampal cultures to confirm the staining patterns. No staining was observed in control experiments in which primary antibodies were omitted and only Alexa Fluor 488-conjugated donkey secondary antibody to chicken was used. Nuclei were stained with propidium iodide.
Mouse cortical cell cultures were prepared from mice at embryonic day 14.5 as described previously 46, 48 . Dissociated cortical cells were plated in 24-well plates coated with poly-d-lysine and laminin in EMEM supplemented with 5% heat-inactivated horse serum, 5% FBS, 2 mM glutamine and glucose (final concentration, 21 mM). Cultures were maintained in a humidified 5% CO 2 incubator at 37 °C for 2 d. Staining was carried out as for the rat hippocampal cultures, except that Kcnt1 was labeled using a Cy3-conjugated donkey secondary antibody to chicken, and nuclei were stained with Topro-3.
